Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction.
The involvement of immune complexes during experimental arthritis in induction of metalloproteinases (MMP)-induced neoepitopes in aggrecan in cartilage, as well as the role of stromelysin-1 (SLN-1) in the induction of this neoepitope, was investigated. Passive immune complex arthritis was induced, and generation of the MMP-specific cleavage product (VDIPEN) was studied by immunolocalization. The role of SLN-1 was studied with use of SLN-1-deficient (SLN-1KO) mice. VDIPEN expression was studied in vitro by exposing the cartilage to IL-1 and subsequent activation of latent MMPs. Immune complex arthritis was characterized by an acute inflammation, with influx of mainly polymorphonuclear cells into the joint cavity. Expression of VDIPEN neoepitopes was consistently found in areas extensively depleted from proteoglycans. SLN-1KO mice did not show expression of the VDIPEN neoepitope, although inflammation and proteoglycan depletion was comparable to wild-type mice. In addition, erosions of cartilage were absent in SLN-1KO mice, but were present in wild-type mice, suggesting an important role for SLN-1 in cartilage destruction. In vitro studies showed that SLN-1 is also pivotally involved in IL-1-induced MMP activity. Stimulated polymorphonuclear neutrophils were able to activate latent MMPs present in the cartilage. Neutrophil elastase was also capable of activating IL-1-induced latent MMPs, which identifies elastase as a possible activator for latent VDIPEN-inducing MMPs. This study suggests that IC are important in the activation of latent MMPs in cartilage, possibly through polymorphonuclear neutrophil activation on the cartilage edge. SLN-1 is a pivotal enzyme in overall MMP-activity in cartilage during immune complex-mediated arthritis.
van Meurs
J
J
Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
van Lent
P
P
Holthuysen
A
A
Lambrou
D
D
Bayne
E
E
Singer
I
I
van den Berg
W
W
D000818:Animals; D001168:Arthritis / Q000201:enzymology* / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D002358:Cartilage, Articular / Q000201:enzymology* / Q000473:pathology; D004789:Enzyme Activation / Q000235:genetics / Q000276:immunology; D000939:Epitopes / Q000096:biosynthesis; D007105:Immune Complex Diseases / Q000201:enzymology* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D007375:Interleukin-1 / Q000494:pharmacology; D019278:Matrix Metalloproteinase 3 / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009504:Neutrophils / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D009842:Oligopeptides / Q000096:biosynthesis; D010446:Peptide Fragments / Q000096:biosynthesis
D000939:Epitopes; D007375:Interleukin-1; D009842:Oligopeptides; D010446:Peptide Fragments; C093378:peptide VDIPEN; D019278:Matrix Metalloproteinase 3